Blog
Implied Volatility Surging for Apollo Global Management Stock Options
Investors in Apollo Global Management, Inc. APO need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 16, 2026 $50 Call had some of the
Here's How Much You'd Have If You Invested $1000 in Burlington Stores a Decade Ago
For most investors, how much a stock's price changes over time is important. Not only can it impact your investment portfolio, but it can also help you compare investment results across sectors and
Here's How Much a $1000 Investment in Idexx Laboratories Made 10 Years Ago Would Be Worth Today
For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and
Here's How Much a $1000 Investment in Oracle Made 10 Years Ago Would Be Worth Today
How much a stock's price changes over time is a significant driver for most investors. Not only can price performance impact your portfolio, but it can help you compare investment results across
Zacks Investment Ideas feature highlights: Apple
For Immediate Release
Chicago, IL – August 12, 2025– Today, Zacks Investment Ideas feature highlights Apple AAPL.
Apple: Navigating Tariffs while Services Drive Growth
Apple Company Overview
Do Options Traders Know Something About AECOM Stock We Don't?
Investors in AECOM ACM need to pay close attention to the stock based on moves in the options market lately. That is because the Sep 19, 2025 $90 Put had some of the highest implied volatility of
TRNO Continues Portfolio-Rebalancing Efforts, Buys Asset in California
Terreno Realty Corporation TRNO recently announced the acquisition of an industrial property in Redondo Beach, CA. The buyout was carried out on Aug. 8 for a purchase value of around $35.5 million
EXAS Stock Dips Despite Q2 Earnings & Revenue Beat, '25 Sales View Up
Exact Sciences Corporation EXAS reported earnings per share (EPS) of 22 cents in the second quarter of 2025 compared to the Zacks Consensus Estimate of a loss of 2 cents. The reported figure
Insulet Q2 Earnings & Revenues Beat Estimates, Stock Up, Margins Rise
Insulet Corporation PODD reported second-quarter 2025 adjusted earnings per share (EPS) of $1.17, up 112.7% from the year-ago period’s figure. The bottom line surpassed the Zacks Consensus Estimate
WES Targets $1.1B Capex in 2026 to Drive Delaware Basin Growth
Western Midstream Partners, LP WES is positioning itself for significant growth in the Delaware Basin with plans to invest at least $1.1 billion in 2026 capital expenditures. The company’s strategy
EYE Stock Gains on Q2 Earnings and Revenue Beat, '25 View Up
National Vision Holdings, Inc. EYE delivered second-quarter 2025 adjusted earnings of 18 cents per share compared with 15 cents a year ago. The figure surpassed the Zacks Consensus Estimate by
VCYT Stock Gains on Q2 Earnings and Revenue Beat, Margins Up
Veracyte, Inc. VCYT delivered second-quarter 2025 adjusted earnings of 44 cents per share, which marked a stupendous improvement of 46.7% from the year-ago period’s figure of 30 cents. The bottom
ISRG's Post-Earnings Slide: Margin Worries Overshadow Growth Story
Intuitive Surgical ISRG posted second-quarter fiscal 2025 results on July 22. It delivered a solid top-line beat and healthy procedure growth, but shares have lost more than 7% since the release
DNLI Tops on Q2 Earnings, Expects Decree on Hunter Syndrome Drug in '26
Denali Therapeutics (DNLI) reported a second-quarter 2025 loss of 72 cents per share, narrower than the Zacks Consensus Estimate of a loss of 74 cents. The company reported a loss of 59 cents in the
Here's Why You Should Include ONE Gas Stock in Your Portfolio Now
ONE Gas, Inc. OGS is benefiting from 100% regulated operations and an expansion of its customer base. The company is also gaining from its strategic investments that help improve its infrastructure
Barrick Mining Q2 Earnings Meet Estimates, Sales Up on Higher Prices
Barrick Mining Corporation B recorded profits (on a reported basis) of $811 million or 47 cents per share for second-quarter 2025, up from $370 million or 21 cents per share in the year-ago quarter
J&J's MedTech Unit Sales Improve in Q2: Will the Upside Continue?
Johnson & Johnson's JNJ medical devices segment, known as MedTech, offers products in the orthopedics, surgery, cardiovascular and vision markets. The MedTech segment accounts for around 36% of
Celanese Q2 Earnings & Sales Beat Estimates Amid Low Prices
Celanese Corporation CE reported second-quarter 2025 earnings from continuing operations of $1.90 per share, which increased from $1.42 in the prior-year quarter.Adjusted earnings were $1.44 per
3 Magnificent Mutual Funds to Maximize Your Retirement Portfolio
It is never too late to invest in mutual funds for retirement. As such, if you plan to invest in some of the best funds, the Zacks Mutual Fund Rank can provide you with valuable guidance.
How can
Are these 3 Top-Ranked Mutual Funds In Your Retirement Portfolio?
Investing in mutual funds for retirement is never too late. And the Zacks Mutual Fund Rank can be an excellent tool for investors looking to invest in the best funds.
The easiest way to judge a
Make the Most of Your Retirement with These Top-Ranked Mutual Funds
There is never a wrong time to invest in mutual funds for retirement. So, if you're still looking for the best mutual funds, the Zacks Mutual Fund Rank can be a great guide.
The best way to
Delek Q2 Loss Narrower Than Expected, Revenues Miss Estimates
Delek US Holdings, Inc. DK reported a second-quarter 2025 adjusted net loss of 56 cents per share, narrower than both the Zacks Consensus Estimate and the year-ago quarter’s loss of 92 cents, due to





